OpenURL Connection Search

Select item for more details and to access through your institution.

Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00915-6
By:
- Hammond, Danielle;
- Loghavi, Sanam;
- Wang, Sa A.;
- Konopleva, Marina Y.;
- Kadia, Tapan M.;
- Daver, Naval G.;
- Ohanian, Maro;
- Issa, Ghayas C.;
- Alvarado, Yesid;
- Short, Nicholas J.;
- Sasaki, Koji;
- Pemmaraju, Naveen;
- Montalban-Bravo, Guillermo;
- Lachowiez, Curtis A.;
- Maiti, Abhishek;
- Garcia-Manero, Guillermo;
- Jabbour, Elias J.;
- Borthakur, Gautam;
- Ravandi, Farhad;
- Takahashi, Koichi
Publication type:
Article
Outcomes of patients with therapy‐related myeloid neoplasms after treatment with poly(ADP‐ribose) polymerase proteins inhibitors for solid tumours.
Published in:
British Journal of Haematology, 2023, v. 201, n. 3, p. e25, doi. 10.1111/bjh.18766
By:
- Almanza‐Huante, Emmanuel;
- Bataller, Alex;
- Urrutia, Samuel;
- Gener‐Ricos, Georgina;
- Briski, Robert Edward;
- Kanagal‐Shamanna, Rashmi;
- Lu, Karen H.;
- Westin, Shannon N.;
- Yap, Timothy A.;
- Takahashi, Koichi;
- Ravandi, Farhad;
- Alvarado, Yesid;
- Kadia, Tapan;
- Sasaki, Koiji;
- Kantarjian, Hagop M.;
- Garcia‐Manero, Guillermo
Publication type:
Article
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome.
Published in:
British Journal of Haematology, 2021, v. 195, n. 3, p. 378, doi. 10.1111/bjh.17689
By:
- Chien, Kelly S.;
- Kim, Kunhwa;
- Nogueras‐Gonzalez, Graciela M.;
- Borthakur, Gautam;
- Naqvi, Kiran;
- Daver, Naval G.;
- Montalban‐Bravo, Guillermo;
- Cortes, Jorge E.;
- DiNardo, Courtney D.;
- Jabbour, Elias;
- Alvarado, Yesid;
- Andreeff, Michael;
- Bose, Prithviraj;
- Jain, Nitin;
- Kadia, Tapan M.;
- Huang, Xuelin;
- Sheppard, Kimberly B.;
- Klingner‐Winton, Cheri;
- Pierce, Sherry A.;
- Dong, Xiao Qin
Publication type:
Article
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
Published in:
British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
By:
- Short, Nicholas J.;
- Kantarjian, Hagop;
- Jabbour, Elias;
- Cortes, Jorge E.;
- Thomas, Deborah A.;
- Rytting, Michael E.;
- Daver, Naval;
- Alvarado, Yesid;
- Konopleva, Marina;
- Kebriaei, Partow;
- Wierda, William G.;
- DiNardo, Courtney D.;
- Bivins, Carol;
- McCue, Deborah;
- Richie, Mary A.;
- Ravandi, Farhad
Publication type:
Article
Performance of IPSS‐M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Published in:
American Journal of Hematology, 2023, v. 98, n. 10, p. E281, doi. 10.1002/ajh.27043
By:
- Urrutia, Samuel;
- Chien, Kelly S.;
- Li, Ziyi;
- Bataller, Alex;
- Almanza, Emmanuel;
- Sasaki, Koji;
- Montalban‐Bravo, Guillermo;
- Short, Nicholas J.;
- Jabbour, Elias;
- Kadia, Tapan M.;
- Ravandi, Farhad;
- Borthakur, Gautam;
- Alvarado, Yesid;
- Daver, Naval;
- Kanagal‐Shamanna, Rashmi;
- Bueso‐Ramos, Carlos;
- Pierce, Sherry A.;
- Kantarjian, Hagop;
- Garcia‐Manero, Guillermo
Publication type:
Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
Published in:
American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
By:
- Haddad, Fadi G.;
- Sasaki, Koji;
- Bidikian, Aram;
- Issa, Ghayas C.;
- Kadia, Tapan;
- Jain, Nitin;
- Alvarado, Yesid;
- Short, Nicholas J.;
- Pemmaraju, Naveen;
- Loghavi, Sanam;
- Patel, Keyur P.;
- Kanagal‐Shamanna, Rashmi;
- Yilmaz, Musa;
- Masarova, Lucia;
- Jabbour, Elias;
- Kantarjian, Hagop
Publication type:
Article
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G‐CSF based regimens.
Published in:
American Journal of Hematology, 2023, v. 98, n. 3, p. E53, doi. 10.1002/ajh.26811
By:
- Senapati, Jayastu;
- Abuasab, Tareq;
- Haddad, Fadi G.;
- Ravandi, Farhad;
- Kadia, Tapan;
- DiNardo, Courtney;
- Daver, Naval;
- Pemmaraju, Naveen;
- Alvarado, Yesid;
- Brandt, Mark A.;
- Kantarjian, Hagop;
- Borthakur, Gautam
Publication type:
Article
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients
Published in:
American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
By:
- Borthakur, Gautam;
- Ravandi, Farhad;
- Patel, Keyur;
- Wang, Xuemei;
- Kadia, Tapan;
- DiNardo, Courtney;
- Garcia‐Manero, Guillermo;
- Pemmaraju, Naveen;
- Jabbour, Elias J.;
- Takahashi, Koichi;
- Ohanian, Maro;
- Daver, Naval;
- Alvarado, Yesid;
- Brandt, Mark;
- Pierce, Sherry;
- Kantarjian, Hagop
Publication type:
Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
Published in:
American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
By:
- Jabbour, Elias;
- Sasaki, Koji;
- Haddad, Fadi G.;
- Issa, Ghayas C.;
- Skinner, Jeffrey;
- Dellasala, Sara;
- Yilmaz, Musa;
- Ferrajoli, Alessandra;
- Bose, Prithviraj;
- Thompson, Philip;
- Alvarado, Yesid;
- Jain, Nitin;
- Garcia‐Manero, Guillermo;
- Takahashi, Koichi;
- Borthakur, Gautam;
- Pemmaraju, Naveen;
- Pierce, Sherry;
- Kantarjian, Hagop
Publication type:
Article
Blinatumomab is associated with favorable outcomes in patients with B‐cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10<sup>−4</sup> and higher.
Published in:
American Journal of Hematology, 2022, v. 97, n. 9, p. 1135, doi. 10.1002/ajh.26634
By:
- Jabbour, Elias J.;
- Short, Nicholas J.;
- Jain, Nitin;
- Jammal, Nadya;
- Jorgensen, Jeffrey;
- Wang, Sa;
- Wang, Xuemei;
- Ohanian, Maro;
- Alvarado, Yesid;
- Kadia, Tapan;
- Sasaki, Koji;
- Garris, Rebecca;
- Garcia‐Manero, Guillermo;
- Ravandi, Farhad;
- Kantarjian, Hagop M.
Publication type:
Article
Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
Published in:
American Journal of Hematology, 2022, v. 97, n. 8, p. 1035, doi. 10.1002/ajh.26601
By:
- DiNardo, Courtney D.;
- Lachowiez, Curtis A.;
- Takahashi, Koichi;
- Loghavi, Sanam;
- Kadia, Tapan;
- Daver, Naval;
- Xiao, Lianchun;
- Adeoti, Maria;
- Short, Nicholas J.;
- Sasaki, Koji;
- Wang, Sa A.;
- Borthakur, Gautam;
- Issa, Ghayas;
- Maiti, Abhishek;
- Alvarado, Yesid;
- Pemmaraju, Naveen;
- Bravo, Guillermo Montalban;
- Masarova, Lucia;
- Yilmaz, Musa;
- Jain, Nitin
Publication type:
Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
Published in:
American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
By:
- Haddad, Fadi G.;
- Sasaki, Koji;
- Issa, Ghayas C.;
- Garcia‐Manero, Guillermo;
- Ravandi, Farhad;
- Kadia, Tapan;
- Cortes, Jorge;
- Konopleva, Marina;
- Pemmaraju, Naveen;
- Alvarado, Yesid;
- Yilmaz, Musa;
- Borthakur, Gautam;
- DiNardo, Courtney;
- Jain, Nitin;
- Daver, Naval;
- Short, Nicholas J.;
- Jabbour, Elias;
- Kantarjian, Hagop
Publication type:
Article
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.
Published in:
American Journal of Hematology, 2022, v. 97, n. 5, p. 574, doi. 10.1002/ajh.26496
By:
- Senapati, Jayastu;
- Shoukier, Mahran;
- Garcia‐Manero, Guillermo;
- Wang, Xuemei;
- Patel, Keyur;
- Kadia, Tapan;
- Ravandi, Farhad;
- Pemmaraju, Naveen;
- Ohanian, Maro;
- Daver, Naval;
- DiNardo, Courtney;
- Alvarado, Yesid;
- Aldrich, Jeffrey;
- Borthakur, Gautam
Publication type:
Article
Decitabine and venetoclax for IDH1/2‐mutated acute myeloid leukemia.
Published in:
American Journal of Hematology, 2021, v. 96, n. 5, p. E154, doi. 10.1002/ajh.26122
By:
- Venugopal, Sangeetha;
- Maiti, Abhishek;
- DiNardo, Courtney D.;
- Loghavi, Sanam;
- Daver, Naval G.;
- Kadia, Tapan M.;
- Rausch, Caitlin R.;
- Alvarado, Yesid;
- Ohanian, Maro;
- Sasaki, Koji;
- Short, Nicholas J.;
- Takahashi, Koichi;
- Yilmaz, Musa;
- Ravandi, Farhad;
- Kantarjian, Hagop M.;
- Konopleva, Marina Y.
Publication type:
Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
Published in:
American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
By:
- Maiti, Abhishek;
- Qiao, Wei;
- Sasaki, Koji;
- Ravandi, Farhad;
- Kadia, Tapan M.;
- Jabbour, Elias J.;
- Daver, Naval G.;
- Borthakur, Gautam;
- Garcia‐Manero, Guillermo;
- Pierce, Sherry A.;
- Montalbano, Kathryn S.;
- Pemmaraju, Naveen;
- Naqvi, Kiran;
- Ohanian, Maro;
- Short, Nicholas J.;
- Alvarado, Yesid;
- Takahashi, Koichi;
- Yilmaz, Musa;
- Jain, Nitin;
- Kornblau, Steven M.
Publication type:
Article
Correction to: A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia.
Published in:
2024
By:
- Babakhanlou, Rodrick;
- Nader, Marc-Elie;
- Alvarado, Yesid
Publication type:
Correction Notice
A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia.
Published in:
Annals of Hematology, 2023, v. 102, n. 12, p. 3427, doi. 10.1007/s00277-023-05433-w
By:
- Babakhanlou, Rodrick;
- Nader, Marc-Elie;
- Alvarado, Yesid
Publication type:
Article
Novel Abl Kinase Inhibitors in Chronic Myeloid Leukemia in Blastic Phase and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia.
Published in:
Clinical Lymphoma & Myeloma, 2007, v. 7, p. S113
By:
- Swords, Ronan;
- Alvarado, Yesid;
- Giles, Francis
Publication type:
Article
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
Published in:
Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582213
By:
- Bannon, Sarah A.;
- Routbort, Mark J.;
- Montalban-Bravo, Guillermo;
- Mehta, Rohtesh S.;
- Jelloul, Fatima Zahra;
- Takahashi, Koichi;
- Daver, Naval;
- Oran, Betul;
- Pemmaraju, Naveen;
- Borthakur, Gautam;
- Naqvi, Kiran;
- Issa, Ghayas;
- Sasaki, Koji;
- Alvarado, Yesid;
- Kadia, Tapan M.;
- Konopleva, Marina;
- Shamanna, Rashmi Kanagal;
- Khoury, Joseph D.;
- Ravandi, Farhad;
- Champlin, Richard
Publication type:
Article
Treatment of Acute Lymphoblastic Leukaemia: A New Era.
Published in:
Drugs, 2007, v. 67, n. 15, p. 2153, doi. 10.2165/00003495-200767150-00004
By:
- Apostolidou, Effrosyni;
- Swords, Ronan;
- Alvarado, Yesid;
- Giles, Francis J.
Publication type:
Article
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
Published in:
2008
By:
- Borthakur, Gautam;
- Alvarado, Yesid;
- Ravandi-Kashani, Farhad;
- Codes, Jorge;
- Estrov, Zeev;
- Faderl, Stefan;
- Ivy, Percy;
- Bueso-Ramos, Carlos;
- Bekele, B. Nebiyou;
- Giles, Francis;
- Cortes, Jorge;
- Nebiyou Bekele, B
Publication type:
journal article
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophagecolony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia
Published in:
Cancer (0008543X), 2003, v. 97, n. 7, p. 1711, doi. 10.1002/cncr.11238
By:
- Apostolia M. Tsimberidou;
- Hagop M. Kantarjian;
- Jorge Cortes;
- Deborah A. Thomas;
- Stefan Faderl;
- Guillermo Garcia-Manero;
- Srdan Verstovsek;
- Alessandra Ferrajoli;
- William Wierda;
- Yesid Alvarado;
- Susan M. O'Brien;
- Maher Albitar;
- Michael J. Keating;
- Francis J. Giles
Publication type:
Article
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 742, doi. 10.1016/j.clml.2023.05.009
By:
- Gener-Ricos, Georgina;
- Haddad, Fadi G.;
- Sasaki, Koji;
- Issa, Ghayas C.;
- Skinner, Jeffrey;
- Masarova, Lucia;
- Borthakur, Gautam;
- Alvarado, Yesid;
- Garcia-Manero, Guillermo;
- Jabbour, Elias;
- Kantarjian, Hagop
Publication type:
Article
MDS-090: Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S339, doi. 10.1016/S2152-2650(21)01791-2
By:
- Venugopal, Sangeetha;
- DiNardo, Courtney D.;
- Takahashi, Koichi;
- Konopleva, Marina;
- Loghavi, Sanam;
- Borthakur, Gautam;
- DeZern, Amy;
- Masarova, Lucia;
- Daver, Naval;
- Short, Nicholas J.;
- Alvarado, Yesid;
- Ravandi, Farhad;
- Montalban-Bravo, Guillermo;
- Sasaki, Koji;
- Delumpa, Ricardo;
- Sekeres, Mikkael A.;
- Patel, Bhumika;
- Roboz, Gail J.;
- Kantarjian, Hagop M.;
- Garcia-Manero, Guillermo
Publication type:
Article
AML-310: Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S303, doi. 10.1016/S2152-2650(21)01721-3
By:
- Siddiqui, Maria;
- Maiti, Abhishek;
- Daver, Naval;
- Kadia, Tapan;
- Rausch, Caitlin;
- Alvarado, Yesid;
- Ohanian, Maro;
- Sasaki, Koji;
- Short, Nicholas;
- Takahashi, Koichi;
- Yilmaz, Musa;
- Ravandi, Farhad;
- Kantarjian, Hagop;
- DiNardo, Courtney;
- Konopleva, Marina
Publication type:
Article
AML-297: Ten-Day Decitabine with Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S303, doi. 10.1016/S2152-2650(21)01720-1
By:
- Maiti, Abhishek;
- DiNardo, Courtney;
- Qiao, Wei;
- Kadia, Tapan;
- Jabbour, Elias;
- Rausch, Caitlin;
- Daver, Naval;
- Short, Nicholas;
- Borthakur, Gautam;
- Pemmaraju, Naveen;
- Yilmaz, Musa;
- Alvarado, Yesid;
- Montalbano, Kathryn;
- Wade, Allison;
- Maduike, Rita;
- Guerrero, Julio;
- Vaughan, Kenneth;
- Bivins, Carol;
- Pierce, Sherry;
- Ning, Jing
Publication type:
Article
AML-204: Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S291, doi. 10.1016/S2152-2650(21)01696-7
By:
- Lachowiez, Curtis;
- Koichi Takahashi;
- Loghavi, Sanam;
- Lianchun Xiao;
- Kadia, Tapan;
- Adeoti, Maria;
- Short, Nicholas;
- Koji Sasaki;
- Sa Wang;
- Borthakur, Gautam;
- Issa, Ghayas;
- Maiti, Abhishek;
- Alvarado, Yesid;
- Pemmaraju, Naveen;
- Bravo, Guillermo Montalban;
- Masarova, Lucia;
- Yilmaz, Musa;
- Nitin Jain;
- Andreeff, Michael;
- Jabbour, Elias
Publication type:
Article
Poster: MDS-090: Phase II Study of the IDH2 Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S226, doi. 10.1016/S2152-2650(21)01427-0
By:
- Venugopal, Sangeetha;
- DiNardo, Courtney D.;
- Takahashi, Koichi;
- Konopleva, Marina;
- Loghavi, Sanam;
- Borthakur, Gautam;
- DeZern, Amy;
- Masarova, Lucia;
- Daver, Naval;
- Short, Nicholas J.;
- Alvarado, Yesid;
- Ravandi, Farhad;
- Montalban-Bravo, Guillermo;
- Sasaki, Koji;
- Delumpa, Ricardo;
- Sekeres, Mikkael A.;
- Patel, Bhumika;
- Roboz, Gail J.;
- Kantarjian, Hagop M.;
- Garcia-Manero, Guillermo
Publication type:
Article
Poster: AML-310: Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S216, doi. 10.1016/S2152-2650(21)01363-X
By:
- Siddiqui, Maria;
- Maiti, Abhishek;
- Daver, Naval;
- Kadia, Tapan;
- Rausch, Caitlin;
- Alvarado, Yesid;
- Ohanian, Maro;
- Sasaki, Koji;
- Short, Nicholas;
- Takahashi, Koichi;
- Yilmaz, Musa;
- Ravandi, Farhad;
- Kantarjian, Hagop;
- DiNardo, Courtney;
- Konopleva, Marina
Publication type:
Article
Poster: AML-297: Ten-Day Decitabine with Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S216, doi. 10.1016/S2152-2650(21)01362-8
By:
- Maiti, Abhishek;
- DiNardo, Courtney;
- Qiao, Wei;
- Kadia, Tapan;
- Jabbour, Elias;
- Rausch, Caitlin;
- Daver, Naval;
- Short, Nicholas;
- Borthakur, Gautam;
- Pemmaraju, Naveen;
- Yilmaz, Musa;
- Alvarado, Yesid;
- Montalbano, Kathryn;
- Wade, Allison;
- Maduike, Rita;
- Guerrero, Julio;
- Vaughan, Kenneth;
- Bivins, Carol;
- Pierce, Sherry;
- Ning, Jing
Publication type:
Article
Poster: AML-204: Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01338-0
By:
- Lachowiez, Curtis;
- Takahashi, Koichi;
- Loghavi, Sanam;
- Xiao, Lianchun;
- Kadia, Tapan;
- Adeoti, Maria;
- Short, Nicholas;
- Sasaki, Koji;
- Wang, Sa;
- Borthakur, Gautam;
- Issa, Ghayas;
- Maiti, Abhishek;
- Alvarado, Yesid;
- Pemmaraju, Naveen;
- Bravo, Guillermo Montalban;
- Masarova, Lucia;
- Yilmaz, Musa;
- Jain, Nitin;
- Andreeff, Michael;
- Jabbour, Elias
Publication type:
Article
Oral Abstract: AML-204: Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01270-2
By:
- Lachowiez, Curtis;
- Takahashi, Koichi;
- Loghavi, Sanam;
- Lianchun Xiao;
- Kadia, Tapan;
- Adeoti, Maria;
- Short, Nicholas;
- Sasaki, Koji;
- Sa Wang;
- Gautam Borthakur;
- Issa, Ghayas;
- Maiti, Abhishek;
- Alvarado, Yesid;
- Pemmaraju, Naveen;
- Bravo, Guillermo Montalban;
- Masarova, Lucia;
- Yilmaz, Musa;
- Jain, Nitin;
- Andreeff, Michael;
- Jabbour, Elias
Publication type:
Article
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Published in:
2020
By:
- Ravandi, Farhad;
- Pierce, Sherry;
- Garcia-Manero, Guillermo;
- Kadia, Tapan;
- Jabbour, Elias;
- Borthakur, Gautam;
- DiNardo, Courtney D.;
- Daver, Naval;
- Short, Nicholas J.;
- Alvarado, Yesid;
- Cortes, Jorge;
- Kim, Christopher;
- Kelsh, Michael;
- Katz, Aaron;
- Williams, Richard;
- Yang, Zhao;
- Mehta, Bhakti;
- Kantarjian, Hagop
Publication type:
journal article
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.
Published in:
2020
By:
- Richard-Carpentier, Guillaume;
- Jabbour, Elias;
- Short, Nicholas J.;
- Rausch, Caitlin R.;
- Savoy, Jonathan M.;
- Bose, Prithviraj;
- Yilmaz, Musa;
- Jain, Nitin;
- Borthakur, Gautam;
- Ohanian, Maro;
- Alvarado, Yesid;
- Rytting, Michael;
- Kebriaei, Partow;
- Konopleva, Marina;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
journal article
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia.
Published in:
2019
By:
- Maiti, Abhishek;
- Naqvi, Kiran;
- Kadia, Tapan M.;
- Borthakur, Gautam;
- Takahashi, Koichi;
- Bose, Prithviraj;
- Daver, Naval G.;
- Patel, Ami;
- Alvarado, Yesid;
- Ohanian, Maro;
- DiNardo, Courtney D.;
- Cortes, Jorge E.;
- Jabbour, Elias J.;
- Garcia-Manero, Guillermo;
- Kantarjian, Hagop M.;
- Ravandi, Farhad
Publication type:
journal article
MEK Inhibitor Binimetinib (MEK162) in Relapse and Refractory Acute Myeloid Leukemia: Results of a Phase I/II Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S199, doi. 10.1016/j.clml.2018.07.046
By:
- Maiti, Abhishek;
- Naqvi, Kiran;
- Kadia, Tapan;
- Borthakur, Gautam;
- Takahashi, Koichi;
- Bose, Prithviraj;
- Daver, Naval;
- Patel, Ami;
- Alvarado, Yesid;
- Ohanian, Maro;
- DiNardo, Courtney;
- Jabbour, Elias;
- Garcia-Manero, Guillermo;
- Kantarjian, Hagop;
- Ravandi, Farhad
Publication type:
Article
Randomized Phase II Study of Guadecitabine (SGI-110) Based Regimens Comparing Guadecitabine 5 days (SGI5), 10 days (SGI10), 5 days + Idarubicin (SGI5 + Ida), and 5 days + Cladribine (SGI5 + Clad), in Previously Untreated Patients ≥ 70 Years with Acute Myeloid Leukemia (AML)--a Bayesian Design.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S6, doi. 10.1016/j.clml.2017.09.032
By:
- Naqvi, Kiran;
- Gonzalez, Garciela Nogueras;
- Cheung, Cora;
- Pemmaraju, Naveen;
- Jabbour, Elias;
- Garcia-Manero, Guillermo;
- DiNardo, Courtney;
- Ohanian, Maro;
- Jain, Nitin;
- Koichi Takahashi;
- Alvarado, Yesid;
- Konopleva, Marina;
- Xuelin Huang;
- Cortes, Jorge;
- Kantarjian, Hagop
Publication type:
Article
Outcomes with Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine as Salvage Therapy for Relapsed/ Refractory Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S3, doi. 10.1016/j.clml.2017.09.028
By:
- Boddu, Prajwal;
- Jain, Nitin;
- Ravandi, Farhad;
- Garcia Manero, Guillermo;
- Borthakur, Gautam;
- Kadia, Tapan;
- Jabbour, Elias J.;
- Pemmaraju, Naveen;
- Daver, Naval;
- DiNardo, Courtney D.;
- Konopleva, Marina;
- Alvarado, Yesid;
- Takahashi, Koichi;
- Benton, Christopher;
- Pike, Allison;
- Pierce, Sherry;
- Cortes, Jorge E.;
- Kantarjian, Hagop M.
Publication type:
Article
The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S3, doi. 10.1016/j.clml.2017.09.027
By:
- Swaminathan, Mahesh;
- Kantarjian, Hagop;
- Daver, Naval;
- Borthakur, Gautam;
- Ohanian, Maro;
- Kadia, Tapan;
- DiNardo, Courtney;
- Jain, Nitin;
- Estrov, Zeev;
- Ferrajoli, Alessandra;
- Garcia-Manero, Guillermo;
- Konopleva, Marina;
- Andreeff, Michael;
- Pemmaraju, Naveen;
- Jabbour, Elias;
- Alvarado, Yesid;
- Wierda, William;
- Pinsoy, Maria Rhona;
- Ravandi, Farhad;
- Cortes, Jorge
Publication type:
Article
Frontline Inotuzumab Ozogamicin with Low-intensity Chemotherapy (mini-hyper-CVD) in Older Patients with Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase I/II Trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S255, doi. 10.1016/j.clml.2017.07.019
By:
- Maiti, Abhishek;
- Kantarjian, Hagop;
- O'Brien, Susan;
- Ravandi, Farhad;
- Short, Nicholas;
- Thomas, Deborah;
- Garcia-Manero, Guillermo;
- Daver, Naval;
- Borthakur, Gautam;
- Jain, Nitin;
- Konopleva, Marina;
- Sasaki, Koji;
- Pemmaraju, Naveen;
- Alvarado, Yesid;
- Jacob, Jovitta;
- Garris, Rebecca;
- Thompson, Philip;
- Cortes, Jorge;
- Jabbour, Elias
Publication type:
Article
Results of Second Salvage Therapy for Acute Myeloid Leukemia in the Modern Era.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S272, doi. 10.1016/j.clml.2017.07.047
By:
- Simkins, Aron;
- DiNardo, Courtney D.;
- Kadia, Tapan;
- Daver, Naval;
- Pemmaraju, Naveen;
- Naqvi, Kiran;
- Ohanian, Maro;
- Takahashi, Koichi;
- Alvarado, Yesid;
- Brandt, Mark;
- Pierce, Sherry;
- Konopleva, Marina;
- Jabbour, Elias;
- Garcia-Manero, Guillermo;
- Cortes, Jorge;
- Ravandi-Kashani, Farhad;
- Kantarjian, Hagop
Publication type:
Article
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia.
Published in:
2003
By:
- Alvarado, Yesid;
- Tsimberidou, Apostolia;
- Kantarjian, Hagop;
- Cortes, Jorge;
- Garcia-Manero, Guillermo;
- Faderl, Stefan;
- Thomas, Deborah;
- Estey, Elihu;
- Giles, Francis J.
Publication type:
journal article
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Published in:
2003
By:
- Alvarado, Yesid;
- Cortes, Jorge;
- Verstovsek, Srdan;
- Thomas, Deborah;
- Faderl, Stephan;
- Estrov, Zeev;
- Kantarjian, Hagop;
- Giles, Francis J.
Publication type:
journal article
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study.
Published in:
2021
By:
- Reville, Patrick K.;
- Kantarjian, Hagop M.;
- Ravandi, Farhad;
- Jabbour, Elias;
- DiNardo, Courtney D.;
- Daver, Naval;
- Pemmaraju, Naveen;
- Ohanian, Maro;
- Alvarado, Yesid;
- Xiao, Lianchun;
- Alatrash, Gheath;
- Loghavi, Sanam;
- Rausch, Caitlin R.;
- Borthakur, Gautam;
- Konopleva, Marina;
- Cortes, Jorge;
- Kadia, Tapan M.
Publication type:
Letter to the Editor
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
Published in:
Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00369
By:
- Boddu, Prajwal;
- Borthakur, Gautam;
- Koneru, Mythili;
- Huang, Xuelin;
- Naqvi, Kiran;
- Wierda, William;
- Bose, Prithviraj;
- Jabbour, Elias;
- Estrov, Zeev;
- Burger, Jan;
- Alvarado, Yesid;
- Dekmush, April;
- Patel, Ami;
- Cavazos, Antonio;
- Han, Lina;
- Cortes, Jorge E.;
- Kantarjian, Hagop;
- Andreeff, Michael;
- Konopleva, Marina
Publication type:
Article
Simultaneous deletion of 3'ETV6 and 5' EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.
Published in:
2016
By:
- Zhenya Tang;
- Guilin Tang;
- Sa A. Wang;
- Xinyan Lu;
- Ken H. Young;
- Bueso-Ramos, Carlos E.;
- Alvarado, Yesid;
- Medeiros, L. Jeffrey;
- Khoury, Joseph D.
Publication type:
Case Study
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01476-8
By:
- Short, Nicholas J.;
- Muftuoglu, Muharrem;
- Ong, Faustine;
- Nasr, Lewis;
- Macaron, Walid;
- Montalban-Bravo, Guillermo;
- Alvarado, Yesid;
- Basyal, Mahesh;
- Daver, Naval;
- Dinardo, Courtney D.;
- Borthakur, Gautam;
- Jain, Nitin;
- Ohanian, Maro;
- Jabbour, Elias;
- Issa, Ghayas C.;
- Qiao, Wei;
- Huang, Xuelin;
- Kanagal-Shamanna, Rashmi;
- Patel, Keyur P.;
- Bose, Prithviraj
Publication type:
Article
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Published in:
Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01444-2
By:
- Kantarjian, Hagop;
- Haddad, Fadi G.;
- Jain, Nitin;
- Sasaki, Koji;
- Short, Nicholas J.;
- Loghavi, Sanam;
- Kanagal-Shamanna, Rashmi;
- Jorgensen, Jeffrey;
- Khouri, Issa;
- Kebriaei, Partow;
- Alvarado, Yesid;
- Kadia, Tapan;
- Paul, Shilpa;
- Garcia-Manero, Guillermo;
- Dabaja, Bouthaina;
- Yilmaz, Musa;
- Jacob, Jovitta;
- Garris, Rebecca;
- O'Brien, Susan;
- Ravandi, Farhad
Publication type:
Article
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome.
Published in:
2019
By:
- Benton, Christopher B.;
- Chien, Kelly S.;
- Tefferi, Ayalew;
- Rodriguez, Jose;
- Ravandi, Farhad;
- Daver, Naval;
- Jabbour, Elias;
- Jain, Nitin;
- Alvarado, Yesid;
- Kwari, Monica;
- Pierce, Sherry;
- Maiti, Abhishek;
- Hornbaker, Marisa;
- Santos, Margarida A.;
- Martinez, Sara;
- Siguero, Mariano;
- Zblewski, Darci;
- Al‐Kali, Aref;
- Hogan, William J.;
- Kantarjian, Hagop
Publication type:
journal article
Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
Published in:
American Journal of Hematology, 2020, v. 95, n. 7, p. 734, doi. 10.1002/ajh.25784
By:
- Sasaki, Koji;
- Kantarjian, Hagop;
- Wierda, William;
- Ravandi‐Kashani, Farhad;
- Jorgensen, Jeffrey;
- Wang, Sa A.;
- Khoury, Joseph;
- Daver, Naval;
- Burger, Jan;
- Di Nardo, Courtney D.;
- Jain, Nitin;
- Short, Nicholas J.;
- Estrov MD, Zeev;
- Konopleva MD, PhD, Marina;
- Ohanian DO, Maro;
- Garcia‐Manero, Guillermo;
- Kadia, Tapan;
- Alvarado‐Valero, Yesid;
- Yilmaz, Musa;
- Pierce, Sherry
Publication type:
Article

Found: 74